Drugs - Real World Outcomes
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q3 | 30.3% | 0.662 | Q2 | 71.0% |
| 2024 | 1.9 | Q3 | 32.9% | 0.673 | Q2 | 72.3% |
| 2023 | 1.9 | Q3 | 36.8% | 0.564 | Q2 | 68.9% |
| 2022 | 2.0 | 33.0% | 0.564 | Q2 | 70.0% | |
| 2021 | — | 24.0% | 0.532 | Q2 | 69.1% | |
| 2020 | — | — | 0.430 | Q3 | 61.7% | |
| 2019 | — | — | 0.559 | Q2 | 70.6% | |
| 2018 | — | — | 0.564 | Q2 | 69.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2198-9788
ISSN
2199-1154
region
Western Europe
coverage
2014-2026